Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic

  title={Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic},
  author={Damian F Ana M Jamileh Peng Charlie David M Cristiana Chr Santomauro Mantilla Herrera Shadid Zheng Ashbaugh and Damian Santomauro and Ana Maria Mantilla Herrera and Jamileh Shadid and Peng Zheng and Charlie Ashbaugh and David M. Pigott and Cristiana Abbafati and Christopher Adolph and Joanne O. Amlag and Aleksandr Y. Aravkin and Bree Bang-Jensen and Gregory J Bertolacci and Sabina Bloom and Rachel Castellano and E Filipa de Castro and Suman Chakrabarti and Jhilik Chattopadhyay and Rebecca M. Cogen and James K. Collins and Xiaochen Dai and William James Dangel and Carolyn Dapper and Amanda Deen and Megan Erickson and Samuel B. Ewald and Abraham D. Flaxman and Joseph Jon Frostad and Nancy Fullman and John R. Giles and Ababi Zergaw Giref and Gaorui Guo and Jiawei He and Monika Helak and Erin N Hulland and Bulat Idrisov and Akiaja Lindstrom and Emily Linebarger and Paulo Andrade Lotufo and Rafael Lozano and Beatrice Magistro and D{\'e}borah Carvalho Malta and Johan M{\aa}nsson and F{\'a}tima Marinho and Ali H. Mokdad and Lorenzo Monasta and Paulami Naik and Shuhei Nomura and James K. O’Halloran and Samuel M. Ostroff and Maja Pa{\vs}ovi{\'c} and Louise Penberthy and Robert C. Reiner Jr. and Grace E Reinke and Antonio Luiz P Ribeiro and Aleksei Sholokhov and Reed J. D. Sorensen and Elena A. Varavikova and Anh Vo and Rebecca L Walcott and Stefanie Watson and Charles Shey Wiysonge and B Zigler and Simon I. Hay and Theo Vos and Christopher J. L. Murray and Harvey A. Whiteford and Alize J Ferrari},
  journal={Lancet (London, England)},
  pages={1700 - 1712}
  • Damian F Ana M Jamileh Peng Charlie David M Cristiana Chr Santomauro Mantilla Herrera Shadid Zheng Ashbaugh , D. Santomauro, +65 authors Alize J Ferrari
  • Published 1 October 2021
  • Medicine
  • Lancet (London, England)
Background Before 2020, mental disorders were leading causes of the global health-related burden, with depressive and anxiety disorders being leading contributors to this burden. The emergence of the COVID-19 pandemic has created an environment where many determinants of poor mental health are exacerbated. The need for up-to-date information on the mental health impacts of COVID-19 in a way that informs health system responses is imperative. In this study, we aimed to quantify the impact of… 

Figures and Tables from this paper

Psychological Distress Before and During the COVID-19 Pandemic: Sociodemographic Inequalities in 11 UK Longitudinal Studies
The substantial deterioration in mental health seen in the UK during the first lockdown did not reverse when lockdown lifted, and a sustained worsening is observed across the COVID-19 pandemic.
Impact on Mental Well-Being and Resilience of Patients with Multiple Chronic Conditions in Different Periods during the Coronavirus Disease 2019 Outbreak in Taiwan
The severity of the COVID-19 outbreak in Taiwan was associated with declines in the ADL, mental well-being, and resilience of patients who sought medical attention, and this period covered the early, peak, and late periods of the outbreak.
Fear, anxiety and depression among pregnant women during COVID-19 pandemic: impacts of healthy eating behaviour and health literacy
HES and HL had positive impacts on protecting pregnant women against anxiety and depression during the COVID-19 crisis where the impacts of healthy eating behaviour (HES) and health literacy (HL) were emphasized.
Long-term effects of COVID-19 on mental health: A systematic review.
The overall effect of the pandemic has been linked with worse psychiatric disorder symptoms, however, the long-term effect from direct COVID-19 infection has been associated with no or mild symptoms.
The effect of COVID-19 vaccinations on self-reported depression and anxiety during February 2021
Using the COVID-19 Trends and Impacts Survey (CTIS), we examine the effect of COVID-19 vaccinations on (self-reported) feelings of depression and anxiety (“depression”), isolation, and worries about
Ketamine—New Possibilities in the Treatment of Depression: A Narrative Review
S-ketamine, which was accepted in March 2019 by the Food and Drug Administration for the treatment of drug-resistant depression, provides a quick antidepressant effect with maximum effectiveness achieved after 24 h, and appears to reduce the occurrence of suicidal thoughts.
The Psychological Gains from COVID-19 Vaccination: Who Benefits the Most?
We quantify the impact of COVID-19 vaccination on psychological well-being using information from a large-scale panel survey representative of the UK population. Exploiting exogenous variation in the
Predictors of Adherence to Smoking Cessation Medications among Current and Ex-Smokers in Australia: Findings from a National Cross-Sectional Survey
Background: Adherence to smoking cessation medications (SCMs) improve the rate of successful quitting. This study aimed to evaluate the level of adherence to SCMs and associated factors among smokers
Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depression
It is expected that this review will promote the investigation of chronotherapy for the treatment of depression, contribute to a better understanding of the relationship between antidepressants and circadian rhythms, and consequently promote the development of new therapeutics.
The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: A critical review across waves
A critical overview on how the COVID-19 pandemic has impacted mental health and how human stress resilience has been shaped by the pandemic on the shorter and longer term is provided.


Increase in prevalence of current mental disorders in the context of COVID-19: analysis of repeated nationwide cross-sectional surveys
Evidence is provided matching concerns that COVID-19-related mental health problems pose a major threat to populations, particularly considering the barriers in service provision posed during lockdown, and an urgent need to scale up mental health promotion and prevention globally.
Prevalence of mental disorders, suicidal ideation and suicides in the general population before and during the COVID-19 pandemic in Norway: A population-based repeated cross-sectional analysis
Except for a decrease in mental disorders in the first pandemic period, the findings suggest stable levels of mental disorders, suicidal ideation and suicide deaths during the first six months of the COVID-19 pandemic compared to pre-pandemic levels.
COVID-19 mental health impact and responses in low-income and middle-income countries: reimagining global mental health.
A vision for the concept of building back better the mental health systems in LMICs with a focus on key strategies is presented, notably, fully integrating mental health in plans for universal health coverage, enhancing access to psychosocial interventions through task sharing, leveraging digital technologies for various mental health tasks, and eliminating coercion in mental health care.
Addressing the public mental health challenge of COVID-19
Public mental health interventions (panel) are even more important during pandemics to prevent the anticipated higher prevalence of mental disorders, the associated consequences, and poor mental wellbeing.
Roadmap to strengthen global mental health systems to tackle the impact of the COVID-19 pandemic
Urgent action is needed to strengthen mental health system in all settings and researchers and researchers should focus on research to develop robust information systems that can be enhanced further by linking with other data sources to run predictive models using artificial intelligence.
How mental health care should change as a consequence of the COVID-19 pandemic
The interconnectedness of the world made society vulnerable to this infection, but it also provides the infrastructure to address previous system failings by disseminating good practices that can result in sustained, efficient, and equitable delivery of mental health-care delivery.
Changes in depression and suicidal ideation under severe lockdown restrictions during the first wave of the COVID-19 pandemic in Spain: a longitudinal study in the general population
Prevalence rates of depression and suicidal ideation did not change significantly from before to after the COVID-19 outbreak, however, the rates of Depression among individuals aged 50+ years showed a significant decrease compared to before the pandemic.
Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition
The goal is to massively increase opportunities for people with MNS disorders to access services without the prospect of discrimination or impoverishment and with the hope of attaining optimal health and social outcomes.
Has increased provision of treatment reduced the prevalence of common mental disorders? Review of the evidence from four countries
These data show that the prevalence of mood and anxiety disorders and symptoms has not decreased, despite substantial increases in the provision of treatment, particularly antidepressants, in industrialized countries from 1990 to 2015.
Suicide trends in the early months of the COVID-19 pandemic: an interrupted time-series analysis of preliminary data from 21 countries.
In high-income and upper-middle-income countries, suicide numbers have remained largely unchanged or declined in the early months of the pandemic compared with the expected levels based on the pre-pandemic period.